Researchers have found that patients with OA may experience some restrictions in social participation. Do your patients with OA participate in social activities regularly?
Controversies exist in the management of chronic kidney disease and comorbidities. Do you think the currently available clinical practice guidelines sufficiently address these controversies?
Catheter-based therapies have emerged as a treatment alternative to systemic thrombolysis and are associated with less risk for bleeding events. Do you think catheter-based therapy is a better alternative...